Expert Plastic Surgery After GLP-1 Medications
– NEWPORT BEACH, CA –You Lost the Weight. Now Let’s Sculpt the Body You Deserve
GLP-1 medications like Ozempic®, Wegovy®, and Mounjaro® can deliver remarkable weight loss — but often leave loose skin, volume loss, and deflation behind. At The Aesthetic Centers, we specialize in the final step: restoring your shape, contour, and confidence.
Why the Weight Loss Is Only Half the Story
GLP-1 Weight Loss Can Leave Behind:
- Loose, sagging skin around the arms, abdomen, thighs, or face
- Deflated or drooping breasts and buttocks
- Hollow cheeks or prematurely aged appearance
- A disconnect between your weight loss and how you feel in your body
What We Can Refine for You
Disclaimer: While a significant number of our patients have undergone weight loss, not all of the individuals shown below experienced weight loss, and those who did may have achieved it through various methods, including GLP-1 medications, bariatric surgery, diet, or exercise.
– FACIAL REJUVENATION –
Deep plane facelift, fat grafting, neck lift — restoring youthful volume after facial thinning
– BREAST RESTORATION –
Breast lift, augmentation and reshaping with implants, fat transfer, or own tissue to restore fullness
– BODY CONTOURING –
Tummy tuck, lower body lift, arm lift, thigh lift — tightening and sculpting where skin is loose
– BUTTOCK RESHAPING –
Buttock lift and augmentation with fat transfer, implants or fat pads t to reverse deflation, without implants
Experience You Can Measure: Why Surgical Volume Matters
When it comes to body contouring after GLP-1 weight loss, precision and experience are everything. These are complex, custom procedures that require a deep understanding of skin behavior, tissue quality, and how the body heals — especially after rapid weight loss.
That’s why surgical volume is more than a number — it’s proof of refined technique, surgical stamina, and consistent outcomes. Here’s how Dr. Agha compares to the average plastic surgeon in the U.S.:
| Procedure | Average number of body procedures performed by a typical Plastic Surgeon per year (ASPS) | Average Number of body procedures performed by Dr. Agha per year | Total Number of Procedures performed by Dr. Agha up to 2022 |
|---|---|---|---|
| Upper arm lift | 2.1 | 20+ | 308 |
| Tummy tuck | 19.8 | 70-75 | 1,047 |
| Buttock Reshaping & Augmentation | 0.8 | 60-65 | 497 |
| Buttock Lift | 0.4 | 30+ | 502 |
| Liposuction | 34 | Over 100 | 1,000s |
| Lower Body Lift + Revisions | 1 | 31+ | 502 |
| Thighplasty | 1.2 | 32+ | 467 |
| Upper Body Lift | 14+ | 223 | |
| DBSM | 14 | 210 | |
| Breast Lift With Implants | 16+ | 243 | |
| Reverse Tummy Tuck | 6+ | 127 |
DR. SIAMAK AGHA MD, PhD, FACS
Innovator, Educator, Scientist & ArtistBoard-certified plastic surgeon, Dr. Siamak Agha has spent the last 20 years perfecting the art of body and face contouring surgery. During this time, Dr. Agha has pioneered new techniques in the field of plastic surgery after weight loss. These include the High-Definition Body Lift, Spiral Thigh Lift, Internal Dermal-Bra Breast Lift, J-Thoracoplasty and various buttocks augmentation and reshaping procedures.
Dr. Siamak Agha is:
- World-renowned Faculty in Body Contouring Surgeries
- Active Member of the American Society of Plastic Surgeons
- Diplomat of the American Board of Plastic Surgery
- Active Member of International Society of Aesthetic Plastic Surgeons
- Member of the Orange County Society of Plastic Surgeons
- Fellow of the American College of Surgeons
- Fellow of the Royal College of Medicine (U.K.)
- Specialized in Plastic Surgery After Weight Loss and Extreme Makeovers
Important Disclaimer:
GLP-1 receptor agonist medications, including semaglutides (such as Ozempic® and Wegovy®) and tirzepatides (such as Mounjaro®), are prescription drugs intended for the management of type 2 diabetes and, in some cases, weight loss under medical supervision. These medications are not suitable for everyone and should only be used as prescribed by a qualified healthcare provider.
Potential side effects of GLP-1 medications may include nausea, vomiting, diarrhea, abdominal pain, and reduced appetite. More serious risks, such as pancreatitis, gallbladder disease, kidney issues, and thyroid tumors, have been reported in some cases. It is essential to discuss your medical history and any pre-existing conditions with your doctor before starting treatment.
This blog is for informational purposes only and does not constitute medical advice. If you are considering GLP-1 medication, consult with a licensed healthcare professional to determine if it is appropriate for you.
Ozempic®, Mounjaro®, and Wegovy® are registered trademarks of their respective manufacturers.